Skip to content

Automated Deep Brain Stimulation Programming Using Functional Mapping

Automated Deep Brain Stimulation Programming Using Functional Mapping

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02765282
Acronym
DBS-Expert
Enrollment
40
Registered
2016-05-06
Start date
2018-10-01
Completion date
2020-06-30
Last updated
2019-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Deep brain stimulation (DBS), Kinesia

Brief summary

Participants will undergo DBS programming guided by the DBS-Expert system and by a clinician per standard care.

Interventions

DEVICEAlgorithm based programming using Kinesia-based assessment

DBS-Expert includes a tablet-based software application (app) for guiding DBS programming and a Kinesia motion sensor unit for automated motor assessment. Algorithms search the programming parameter space to resolve an optimal set of programming parameters.

Sponsors

Wake Forest University Health Sciences
CollaboratorOTHER
Ohio State University
CollaboratorOTHER
Wake Forest University
CollaboratorOTHER
Great Lakes NeuroTechnologies Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* The ability to provide informed consent * Clinical diagnosis of idiopathic Parkinson's disease (PD) * Implanted deep brain stimulation (DBS) system for tremor and/or bradykinesia

Exclusion criteria

* Significant medical or psychiatric illness or dementia as evidenced by a score less than 26 on the Montreal Cognitive Assessment * Not capable of functioning independently * Individuals so symptomatic as to compromise safety

Design outcomes

Primary

MeasureTime frameDescription
Programming time when programmed using Kinesia-based assessment (DBS-Expert) compared to programming time when programmed by a clinicianUp to 2 hours (from start of programming session until end of programming session)Amount of time it took to arrive at DBS settings that provide sufficient therapeutic benefit will be compared across programming sessions

Countries

United States

Contacts

Primary ContactDustin A Heldman, PhD
dheldman@glneurotech.com2163615410

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026